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Background and objective: The fall risk assessment tool (FRAT-up) is a tool for predicting falls in
community-dwelling older people based on a meta-analysis of fall risk factors. Based on the fall risk
factor proﬁle, this tool calculates the individual risk of falling over the next year. The objective of this
study is to evaluate the performance of FRAT-up in predicting future falls in multiple cohorts.
Methods: Information about fall risk factors in 4 European cohorts of older people [Activity and Function
in the Elderly (ActiFE), Germany; English Longitudinal Study of Aging (ELSA), England; Invecchiare nel
Chianti (InCHIANTI), Italy; Irish Longitudinal Study on Aging (TILDA), Ireland] was used to calculate the
FRAT-up risk score in individual participants. Information about falls that occurred after the assessment
of the risk factors was collected from subsequent longitudinal follow-ups. We compared the performance
of FRAT-up against those of other prediction models speciﬁcally ﬁtted in each cohort by calculation of the
area under the receiver operating characteristic curve (AUC).
Results: The AUC attained by FRAT-up is 0.562 [95% conﬁdence interval (CI) 0.530e0.594] for ActiFE, 0.699
(95% CI 0.680e0.718) for ELSA, 0.636 (95% CI 0.594e0.681) for InCHIANTI, and 0.685 (95% CI 0.660e0.709)
for TILDA. Mean FRAT-up AUC as estimated from meta-analysis is 0.646 (95% CI 0.584e0.708), with sub-
stantial heterogeneity between studies. In each cohort, FRAT-up discriminant ability is surpassed, at most,
by the cohort-speciﬁc risk model ﬁtted on that same cohort.
Conclusions: We conclude that FRAT-up is a valid approach to estimate risk of falls in populations of
community-dwelling older people. However, further studies should be performed to better understand
the reasons for the observed heterogeneity across studies and to reﬁne a tool that performs homoge-
neously with higher accuracy measures across different populations.
 2016 AMDA e The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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and Long-Term Care Medicine. Puinformation about epidemiologic measures, such as incidence and
prevalence, knowledge of the natural history, risk factors, or risk in-
dicators, has allowed the development of condition-speciﬁc predic-
tion tools.1e8 Such tools express the likelihood that an individual
under assessment will experience the undesired condition of interest
within a given time span. They are used in public health, medical
research, and clinical practice for identiﬁcation of high-risk persons
who can be targeted for cost-effective preventive interventions.9e11
Falls are highly prevalent in older people. They are associated with
increased morbidity and even mortality. Falls are a major cause ofblished by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
P. Palumbo et al. / JAMDA 17 (2016) 1106e1113 1107deterioration in quality of life because they can result in physical in-
juries (eg, fractures) and negative psychological attitudes, such as loss
of self-efﬁcacy. Fall prevention interventions can beneﬁt fromvalid fall
prediction tools.12e14 Although many such tools have been proposed,
only a few of them have been extensively validated and have been
found to have only modest predictive accuracy.6,15e21
Recently, Cattelani et al22 proposed a new prediction tool for falls
in community-dwelling older people called (FRAT-up). It calculates
the risk of falling for an individual, expressed as the probability of
falling within the next 12 months. The tool is freely available online.23
Its architecture can be outlined as the cascade of 2 building blocks. The
ﬁrst block receives some clinical variables of the person under
observation, that the authors called “risk estimators”, and estimates
the person’s exposure to a list of FRAT-up-deﬁned fall risk factors. The
second block uses this information about exposure to the risk factors
and calculates the probability of falling. When applying FRAT-up on
datasets of different studies, the ﬁrst block acts as a “harmonization
block,” which adapts to different risk estimators included in each
dataset (ie, different clinical scales, medical instruments, or protocols)
and converts this information into risk factor exposures (ie, whether
the person has vision impairments, gait problems, etc). The second
block remains unchanged across different datasets and can be
considered as the “core block.” This architecture makes FRAT-up a
ﬂexible tool and allows it to be used across studies where different risk
estimators were used to estimate the fall risk factors, which is the
usual case.
All the parameters of the core block of FRAT-up were derived from
the literature. In particular, the parameters that determine the
contribution of each risk factor to the overall risk of falling were
determined from the odds ratios obtained in the systematic review
and meta-analysis by Deandrea et al.24 Until now, FRAT-up has been
evaluated only in the Invecchiare nel Chianti (InCHIANTI) cohort.22
However, because the meta-analysis by Deandrea collated results
from numerous epidemiologic studies, with risk factors assessed by
different risk estimators, we hypothesize that FRAT-up is a suitable
screening tool for different populations and can be adapted to
different methods for risk factors assessment (ie, different risk
estimators).
With the present study, we aim to further validate FRAT-up and
verify this hypothesis, evaluating its predictive performance on 4
datasets from relevant European epidemiologic studies including
community-dwelling older adults. The performance of a predictive
model depends on the model itself but also on the cohort on which it
is tested. To gain better insight on the robustness of FRAT-up perfor-
mance across different datasets, we also aim to compare the predictive
performance of FRAT-up with data-driven prediction models, each
speciﬁcally ﬁtted on 1 of the 4 cohorts.
Methods
The FRAT-up validation process is described in this article in
compliance with the Transparent Reporting of a Multivariable Pre-
diction Model for Individual Prognosis or Diagnosis checklist for
transparent reporting.25,26 To achieve the objectives listed above, we
used 4 datasets from cohort studies conducted in different European
countries (Germany, England, Italy, and Ireland). The 4 datasets were
initially harmonized to obtain estimates of risk exposure on a standard
list of risk factors. The FRAT-up risk score was calculated and 4 cohort-
speciﬁc prediction models were developed for comparison. All ana-
lyses were run with R version 3.0.2 (R Core Team, Vienna, Austria).27
Included Study Populations
The Activity and Function in the Elderly (ActiFE) in Ulm study is a
population-based observational study on a cohort of community-dwelling older adults. Its principal aim is to investigate the relation-
ship of physical activity, measured with body-worn accelerometers,
with a number of health outcomes. The study design has been pre-
viously described in detail.28,29 Brieﬂy, inclusion criteria were living in
the area of greater Ulm or Neu-Ulm, located in the South of Germany;
being 65 to 90 year old; not being institutionalized; being able to walk
independently through their own room; not having serious difﬁculties
in German language, and no severe deﬁcits in cognition. Older age
strata were oversampled to recruit an equal number of persons for
each age group. At baseline (2009e2010), 1506 participants were
assessed on a number of health parameters, including the fall risk
estimators used in the present study. Successively, they were pro-
spectively followed for 12 months to monitor the occurrence of falls
using fall calendars as recommended by the Profane consortium.30We
excluded 90 people (6%) on whom follow-up information about falls
was missing.
The English Longitudinal Study of Aging (ELSA) is a panel study of a
cohort that is representative of the population of noninstitutionalized
men and women aged 50 years or older living in England. Its broad
scope is to study aging in England in its health, economic, and social
aspects.31 In 2004e2005 (wave 2), the participants underwent a home
interview and a nurse visit, which included the fall risk estimators
used in the present study.32 About 2 years later (wave 3), they were
asked about falls experienced since the last interview.33 Four thou-
sand ﬁfty-six participants aged 65 years or older concluded the
interview and the nurse visit. Of those, we excluded 753 (19%) par-
ticipants that at wave 3 were not reinterviewed or did not answer
questions about experienced falls.
The InCHIANTI study is an observational cohort study on older
adults living in the Chianti region, Italy. Its principal aim is to inves-
tigate the factors contributing to the decline of mobility in older
persons and to establish clinical variables and thresholds to evaluate
mobility in geriatric practice.34 The invited persons were sampled
from themunicipality registries of Greve in Chianti and Bagno a Ripoli.
Those aged 90 years or older were oversampled. At baseline
(1999e2000), 1155 participants aged 65 years or older were assessed
on a number of health parameters, including the fall risk estimators
considered in the present study. After 3 years, they were re-
interviewed and asked about falls experienced during the previous
12 months. We excluded 263 (23%) participants who at the ﬁrst
follow-up were not re-interviewed or did not answer questions about
previous falls.
The Irish Longitudinal Study on Aging (TILDA) is a cohort study
representative of noninstitutionalized men and women aged 50 years
or older living in Ireland. It aims to study aging in Ireland in its health,
economic, and social aspects.35e37 The ﬁeldwork relative to the
baseline was carried out between October 2009 and February 2011. At
baseline, the participants were asked about falls experienced during
the last year andwere assessed on a number of fall risk estimators. The
ﬁrst follow-up was carried out after about 2 years (from April 2012 to
January 2013). At the follow-up, the participants were asked about
falls experienced since the baseline interview. Two thousand three
hundred seventy-two participants aged 65 years or older concluded
the interview and the health assessment. We excluded 271 (11%)
participants who at the ﬁrst follow-up were not re-interviewed or did
not answer questions about experienced falls. TILDA and ELSA are
considered sister surveys, as both were designed similarly according
to the United States Health and Retirement Study.38
Each of these 4 studies has received ethical approval by local
competent ethics committees.
Variable Harmonization
We had to develop 4 harmonization blocks because the 4 cohort
studies are different in theway they were designed and carried out. The
P. Palumbo et al. / JAMDA 17 (2016) 1106e11131108process of deriving common variables from different existing datasets is
often called “retrospective harmonization.” It allows the utilization of
data coming from different sources within 1 combined analysis.39 We
call “target variables” the variables that are desired as a result of the
harmonization process. We distinguish between “predictor target vari-
ables” and an “outcome target variable.” Predictor target variables are all
the fall risk factors obtained as output of FRAT-up harmonization block
and taken as input by the FRAT-up core block. The outcome target var-
iable is the object of prediction (ie, occurrence of any fall during 1 yearTable 1
Main Baseline Characteristics of the 4 Included Cohorts Estimated Using Sample Weight
ActiFE ELSA
Number of participants (n) 1416 3303
Predictor harmonized variables
Age (years): mean (SD) 75.70 (6.76) 74.56 (7.31)
Sex (women) 56.8% 56.7%
1-year history of
falls (yes/no)
36.1% [1.3%] 22.7% [0.4%]
Living alone 27.7% [1.6%] 34.1%
Walking aid use 1.4% [8.5%] 9.3% [1.0%]
Urinary incontinence 41.0% [1.4%] 17.4% [0.1%]
Diabetes mellitus 12.3% [0.3%] 10.8%
Parkinson disease 1.6% 0.7%






History of stroke 4.9% [0.4%] 6.8%
Depression (current
depressive symptoms)
11.3% [5.2%] 10.0% [0.03%]
Poor self-perceived
health status
16.2% [0.5%] NA [100%]
Pain (chronic or
occasional)
60.5% [0.6%] 43.1% [0.4%]
Physical disability
(difﬁculties in
activities of daily living)





14.4% [1.9%] 14.4% [0.03%]
Reported fear of falling 11.3% [1.4%] 7.5% [0.03%]
History of dizziness 42.0% [1.0%] 22.4% [1.7%]
Current vision impairment 83.9% [1.7%] 25.5%
Current hearing impairment 24.2% [1.7%] 27.2%
Number of medications:
mean (SD)
3.62 (2.90) NA [100%]
Use of antihypertensives 56.4% NA [100%]
Use of sedatives 1.3% NA [100%]
Use of antiepileptics 1.7% NA [100%]
Physical activity limitations 14.0% [14.3%] 8.1% [0.09%]
Gait problems 22.5% [3.0%] 31.8% [8.1%]
Outcome harmonized variable
Subsequent falls (yes/no) 32.9% 1-year adjusted: 22.1%
(2 years 33.5%)
Other characteristics
Grip strength (kg): mean (SD) 32.18 (11.09) [1.8%] 26.38 (10.17) [2.0%]
Gait speed (m/s): mean (SD) 0.96 (0.29) [5.3%] 0.85 (0.25) [8.5%]
SPPB balance subscore: mean (SD) 3.68 (0.81) [2.5%] 3.27 (1.24) [0.03%]
SPPB gait subscore: mean (SD) 3.59 (0.91) [3.0%] 3.47 (0.89) [8.1%]
SPPB chair standing subscore:
mean (SD)
3.16 (1.16) [1.6%] 2.40 (1.45) [6.0%]
SPPB score: mean (SD) 10.45 (2.36) [5.6%] 9.46 (2.67) [13.1%]
NA, not available; SD, standard deviation.
If values were missing, percentage of missing values is indicated in square brackets.
*Values from Cattelani et al.22
yNot available because of lack of information about fall counts.after the assessment, hereinafter “subsequent falls”). We call “source
variables” the variables that are native of each dataset and that are used
to construct the target variables. Predictor source variables are the risk
estimators received in input by the FRAT-up harmonization block.
For each dataset, harmonization rules were developed and applied
whenever possible to construct the target variables from the source
variables. This process was fully blinded, meaning that the effect of the
different choices of the harmonization process on the performance of
any predictive model was not evaluated.s
InCHIANTI TILDA Prevalence Used by FRAT-up*
892 2101






20.8% 22.8% [0.05%] 31%
18.2% 31.1% 32%
8.2% [6.4%] 1.6% 18%
34.3% 17.2% [0.5%] 19%
12.9% 10.5% 11%
1.3% [0.8%] NA [100%] 0.8%
34.7% 41.0% 47%
10.5% 2.5% [0.2%] 19%
5.8% [0.2%] 3.1% 13%
16.9% [2.5%] 3.3% [1.5%] 13%
6.4% [2.6%] 5.9% 20%
87.6% [0.4%] 39.3% [0.1%] 30%
5.6% 4.6% 11%
21.3% 5.1% 37%
37.4% [0.1%] 32.3% [0.1%] 33%
35.1% [6.6%] 26.5% [0.2%] 20%
54.3% [14.6%] 42.4% [23.2%] 19%
24.1% [5.8%] 22.2% 36%
2.18 (2.03) 3.86 (2.87) [0.8%] 0: 23.7%, 1: 22.6%,
2: 19.4%, 3: 13.3%, 4: 8.1%
5: 4.9%, 6: 3.6%, 7: 2.0%
8: 1.0%, 9: 0.7%, 10: 0.7%
37.5% 57.7% 32%
5.7% NA [100%] 14%
1.4% NA [100%] 1%
19.8% [0.3%] 36.3% [0.5%] 56%
18.4% [8.0%] 17.3% [18.4%] 42%
22.8% 1-year adjusted:
NAy (2 years 27.1%)
29.92 (11.62) [18.9%] 24.00 (8.86) [0.6%]
1.02 (0.26) [9.9%] NA [100%]
3.38 (1.13) [6.5%] NA [100%]
3.67 (0.81) [8.0%] NA [100%]
3.16 (1.22) [6.7%] NA [100%]
10.23 (2.78) [8.3%] NA [100%]
P. Palumbo et al. / JAMDA 17 (2016) 1106e1113 1109It was considered impossible to construct 5 and 3 risk factors in the
ELSA and TILDA datasets, respectively. The outcome variable was
harmonized imperfectly in all the datasets except ActiFE. In the
InCHIANTI dataset, the corresponding source variable is relative to a
time span that comes 2 years after the assessment, whereas in the
ELSA and TILDA datasets, the corresponding source variables are
relative to a time span that covers 2 years instead of 1. A more detailed
description of the source and target variables and of the harmoniza-
tion process is provided in an Appendix that is available upon request
from the corresponding author.
Statistical Analysis
Use of sample weights
In health surveys, it is often the case that the study sample, which
is available for the analyses, is not fully representative for the target
population. This happens because some population strata are pur-
posely oversampled or because there can be differential response and
drop-out rates. As a consequence, it may happen that the distribution
of some quantities of interest in the sample population differs sub-
stantially from the distribution in the target population. Sample
weights are, thus, used to make sample estimates closer to their
respective target population quantities.40
The ELSA and TILDA datasets are released with a set of sample
weights. Among those, for ELSA, we have considered the weights
assigned to the participants who underwent the nurse visit. For TILDA,
we have considered the weights assigned to the participants who
completed the health assessment, either at home or at the health
center. The weights for the samples of the ActiFE and InCHIANTI
datasets were calculated after stratifying by age group and sex (for the
InCHIANTI we also stratiﬁed by site, Greve in Chianti or Bagno a
Ripoli34). More in particular, each participant in stratum h was
assigned a weight Nh/nh, with Nh (nh) being the total number of par-
ticipants in stratum h in the target population (in the available sample,
respectively).Table 2
Univariate Associations (ORs) With Risk of Subsequent Falls, as Estimated From the 4 Da
Odds Ratio (95% CI)
ActiFE ELSA (2-yea
Age (5-year increase) 1.04 (0.95e1.13) 1.32 (1.25e
Sex (women) 1.40 (1.12e1.75) 1.44 (1.24e
1-year history of falls (yes/no) 1.58 (1.25e1.99) 8.40 (6.68e
Living alone 1.06 (0.82e1.38) 1.63 (1.40e
Walking aid use 1.53 (0.62e3.81) 2.92 (2.27e
Urinary incontinence 1.58 (1.26e1.99) 1.73 (1.44e
Diabetes mellitus 0.94 (0.67e1.31) 1.24 (0.99e
Parkinson disease 1.40 (0.63e3.15) 4.48 (1.82e
History of arthritis or rheumatism 1.34 (1.07e1.68) 1.72 (1.48e
Cognition impairment (moderate to severe) 1.82 (0.47e7.13) 1.84 (0.71e
History of stroke 0.95 (0.57e1.57) 1.90 (1.44e
Depression (current depressive symptoms) 1.14 (0.79e1.65) 1.72 (1.36e
Poor self-perceived health status 1.23 (0.91e1.66) NA
Pain (chronic or occasional) 1.18 (0.94e1.48) 1.67 (1.44e
Physical disability 1.52 (0.84e2.74) 2.63 (2.19e
Instrumental disability 1.27 (0.91e1.78) 2.43 (1.98e
Reported fear of falling 1.43 (1.01e2.03) 3.50 (2.64e
History of dizziness 1.12 (0.89e1.40) 2.55 (2.15e
Current vision impairment 0.95 (0.70e1.30) 1.64 (1.39e
Current hearing impairment 1.23 (0.95e1.59) 1.37 (1.17e
Number of medications (1-drug increase) 1.03 (0.99e1.07) NA
Use of antihypertensives 1.11 (0.89e1.40) NA
Use of sedatives 0.52 (0.17e1.56) NA
Use of antiepileptics 2.63 (1.25e5.52) NA
Physical activity limitations 1.11 (0.79e1.56) 2.14 (1.63e
Gait problems 1.02 (0.77e1.35) 1.94 (1.64e
Statistical signiﬁcant ORSs are reported in bold.
*Values from Deandrea et al.24Data imputation
Missing data are less of an issue for FRAT-up because of the ability
of the tool to handle missing information through use of prevalence
proportions.22 Conversely, missing data imputation is a necessary
preprocessing step before computation of the data-driven models.
Missing data have been imputed in 11 copies with multivariate im-
putations by chained equations.41 Percentage of missing values, when
different from zero, is indicated in square brackets in Table 1. Totally
missing variables in a dataset (eg, number of medications in the ELSA
dataset) were replaced with the prevalence rates used in FRAT-up
(Table 1).
Descriptive statistics
Descriptive statistics of the 4 cohorts were calculated for the
harmonized variables using sample weights. Univariate associations
between single risk factors and subsequent falls were quantiﬁed with
odds ratios (ORs) and corresponding 95% conﬁdence intervals (CIs).
Development of cohort-speciﬁc risk models
FRAT-up was applied on the 4 harmonized datasets. Its perfor-
mance on the datasets was then compared with the performances of
data-driven, cohort-speciﬁc risk models, estimated by 10-fold cross-
validation.
In particular, each harmonized dataset was once used as a
training set and, to this aim, randomly divided in 10 folds, balanced
with respect to number of fallers. In turn, one of the imputed copies
of 9 folds was used to ﬁt a stepwise logistic regression with Akaike
information criterion as model selection metrics.42 All FRAT-up risk
factors were included as candidate regressors, together with their
2-way interactions. This regression model was then used to calculate
the risk score on the test fold of the same dataset. This procedure was
repeated 10 times, to calculate risk scores on all the samples of the
dataset. One randomly chosen model among these 10 was used to
obtain risk scores also on the other 3 harmonized datasets used as
testing sets.tasets and as Reported in the Meta-analysis by Deandrea et al24
r Risk) InCHIANTI TILDA (2-year Risk) Deandrea et al*
1.39) 1.18 (1.06e1.32) 1.14 (1.04e1.26) 1.12 (1.07e1.17)
1.67) 1.47 (1.07e2.03) 1.49 (1.23e1.81) 1.30 (1.18e1.42)
10.55) 1.89 (1.33e2.69) 3.50 (2.82e4.34) 2.77 (2.37e3.25)
1.89) 1.38 (0.94e2.03) 1.46 (1.19e1.80) 1.33 (1.21e1.45)
3.77) 1.74 (1.02e2.95) 3.23 (1.44e7.26) 2.18 (1.79e2.65)
2.08) 1.32 (0.96e1.81) 1.61 (1.26e2.06) 1.40 (1.26e1.57)
1.56) 1.17 (0.75e1.82) 1.08 (0.79e1.48) 1.19 (1.08e1.31)
11.01) 0.70 (0.15e3.26) NA 2.71 (1.08e6.84)
1.99) 1.69 (1.22e2.33) 1.63 (1.34e1.98) 1.47 (1.28e1.70)
4.79) 1.50 (0.94e2.39) 0.86 (0.39e1.92) 1.36 (1.12e1.65)
2.51) 1.05 (0.51e2.18) 2.88 (1.70e4.89) 1.61 (1.31e1.98)
2.18) 2.16 (1.49e3.13) 1.93 (1.16e3.23) 1.63 (1.36e1.94)
2.22 (1.32e3.72) 2.30 (1.55e3.41) 1.50 (1.15e1.96)
1.93) 1.51 (0.91e2.50) 2.11 (1.73e2.56) 1.39 (1.19e1.62)
3.15) 2.24 (1.23e4.08) 2.15 (1.36e3.40) 1.56 (1.22e1.99)
2.99) 2.16 (1.53e3.05) 2.68 (1.71e4.19) 1.46 (1.20e1.77)
4.63) 1.87 (1.37e2.57) 2.28 (1.86e2.79) 1.55 (1.14e2.09)
3.03) 1.01 (0.72e1.41) 1.98 (1.59e2.45) 1.80 (1.39e2.33)
1.94) 1.51 (1.05e2.17) 1.04 (0.82e1.31) 1.35 (1.18e1.54)
1.61) 1.18 (0.83e1.67) 1.43 (1.13e1.80) 1.21 (1.05e1.39)
1.11 (1.03e1.19) 1.10 (1.06e1.13) 1.06 (1.04e1.08)
NA 1.09 (0.90e1.32) 1.25 (1.06e1.48)
NA NA 1.38 (1.15e1.66)
NA NA 1.88 (1.02e3.49)
2.79) 2.44 (1.70e3.49) 1.36 (1.11e1.66) 1.20 (1.04e1.38)
2.28) 2.39 (1.65e3.47) 1.55 (1.13e2.11) 2.06 (1.82e2.33)
Table 3
Comparison Among Models Applied on the 4 Cohorts
AUC (95% CI)
ActiFE ELSA InCHIANTI TILDA
FRAT-up 0.562 (0.530e0.594) 0.699 (0.680e0.718) 0.636 (0.594e0.681) 0.685 (0.660e0.709)
Cohort-speciﬁc model ﬁtted on ActiFE 0.574 (0.541e0.604) 0.566 (0.545e0.585) 0.549 (0.505e0.594) 0.559 (0.532e0.584)
Cohort-speciﬁc model ﬁtted on ELSA 0.560 (0.527e0.593) 0.719 (0.698e0.739) 0.611 (0.570e0.654) 0.675 (0.648e0.704)
Cohort-speciﬁc model ﬁtted on InCHIANTI 0.530 (0.501e0.559) 0.664 (0.644e0.681) 0.571 (0.520e 0.619) 0.633 (0.608e0.661)
Cohort-speciﬁc model ﬁtted on TILDA 0.561 (0.527e0.592) 0.661 (0.642e0.678) 0.600 (0.558e0.647) 0.686 (0.660e0.710)
The discriminative ability is quantiﬁed with AUC (95% CI). The results from internal validation (ﬁtting and testing on the same cohort) are in italics.
P. Palumbo et al. / JAMDA 17 (2016) 1106e11131110To calculate risk scores, each regressionmodel was applied on each
imputed copy of the samples, obtaining 11 risk scores for each
participant. These 11 scores were then averaged to obtain a unique
risk score for each participant.
Model evaluation
The area under the receiver operating characteristic curve (AUC)
was chosen to evaluate FRAT-up and the other cohort-speciﬁc risk
models because this is the most common statistics to evaluate the
discriminative ability of prediction models. Mean and 95% CIs for
model AUCs were derived by means of bootstrapping.43,44 Observa-
tions were sampled with replacement with probability proportional
to their sample weights.
FRAT-up was also graphically evaluated for calibration. To draw the
calibration plot, the FRAT-up 1-year risk of falling (p1) was adjusted to
a 2-year risk of falling (p2) for the ELSA and the TILDA dataset ac-
cording to the formula p2 ¼ p1(2p1). The method is further
explained in the Appendix, available upon request from the corre-
sponding author.
The values of FRAT-up AUCs attained on the 4 populations were
pooled with random effects meta-analysis using the R package
“meta.”45 In particular, mean AUCwas estimatedwith inverse variance
weighted average. Between-study heterogeneity was quantiﬁed with
Higgins-Thompson I2,46 and between-study variance with the
DerSimonian-Laird estimate.47Results
Table 1 describes the 4 cohorts with respect to main sociodemo-
graphic and medical characteristics as obtained after the harmoniza-
tion process. Most characteristics showed a large variation and
difference among the 4 cohorts, except sex, history of diabetes, and
use of antiepileptics.
Table 2 reports for each cohort univariate associations of the single
risk factors with risk of subsequent falls. ORs quantiﬁed in the meta-Fig. 1. Forest plot of random effect meta-analysis for AUC atanalysis by Deandrea et al24 and used by FRAT-up are reported for
comparison. As expected, most ORs are statistically signiﬁcant in ELSA,
InCHIANTI, and TILDA. Surprisingly, only 6 ORs are statistically sig-
niﬁcant in the ActiFE dataset. History of falls is among the strongest
risk factors. In ELSA, the exceptionally high OR may be explained by
the particular predictor and outcome source variables employed.
Table 3 reports the AUCs attained by FRAT-up and by the cohort-
speciﬁc risk models on the 4 cohorts. The AUC of FRAT-up is 0.562
(95% CI 0.530e0.594), 0.699 (95% CI 0.680e0.718), 0.636 (95% CI
0.594e0.681), and 0.685 (95% CI 0.660e0.709) respectively, for ActiFE,
ELSA, InCHIANTI, and TILDA. In each cohort, FRAT-up discriminant
ability is surpassed, at most, by the cohort-speciﬁc riskmodel ﬁtted on
that same cohort. On the InCHIANTI cohort, FRAT-up has higher
discriminative accuracy than the InCHIANTI-speciﬁc risk model.
The mean FRAT-up AUC estimated by pooling results obtained on
the 4 cohorts with random effects meta-analysis is 0.646 (95% CI
0.584e0.708). The between-cohort variance is 0.0038 and the
Higgins-Thompson I2 measure of heterogeneity is 95.1% (95% CI
90.3%e97.5%). Cochran’s Q-test for heterogeneity is highly signiﬁcant
(P < .0001) indicating substantial heterogeneity among the included
studies (Figure 1).
Figure 2 shows the calibration curves of FRAT-up for the 4 datasets.
Participants of ActiFE with low (high) risk scores, experienced more
(respectively, less) falls than expected. This pattern, sometimes
referred to as low resolution,48 is also present in the participants of
InCHIANTI who were assigned to the lowest or highest risk score
deciles. In ELSA and TILDA, FRAT-up overestimated the risk consis-
tently across the risk strata.Discussion
In this comparative study, we investigated the performance of
FRAT-up as a prediction tool for falls in 4 cohorts of European
community-dwelling older adults, and we compared its discrimina-
tive ability with those of cohort-speciﬁc, data-driven risk models.tained by FRAT-up on the 4 cohorts. SE, standard error.
Fig. 2. Calibration plot for FRAT-up fall risk score on the 4 datasets. The calibration curves for ELSA and TILDA are relative to falls occurred during a time span of 2 years. Error bars
indicate 95% CIs.
P. Palumbo et al. / JAMDA 17 (2016) 1106e1113 1111Overall, FRAT-up seems suitable to be applied across different cohorts,
thereby being a valid approach to estimate risk of falls in populations
of community-dwelling older adults, although the performance varied
among the different cohorts.
FRAT-up mean AUC for any fall was estimated to be 0.646 bymeta-
analysis of the AUCs obtained from the 4 cohorts. Compared with
prediction tools for other health outcomes, such as prediction tools for
cardiovascular health,1 this value per se cannot be considered high.
However, previous research has already shown that the FRAT-up
discriminative ability is superior to other screening tools,49 such as
gait speed and the Short Physical Performance Battery (SPPB).50 Also,
the Timed Up and Go test has been shown to have discriminative
ability for falls similar to gait speed.51 Its ability to predict falls6,15 has
been quantiﬁed with an AUC ranging from 0.6152 to 0.71 (value ob-
tained when discriminating recurrent fallers).53 The AUC of the Tinetti
Balance test54 has been reported to be around 0.5652 and 0.62.55 Thus,
the risk models for falls that have been proposed and validated so far,
have left a conspicuous part of the phenomenon unexplained.
Nevertheless, these considerations and the results of our study sug-
gest that FRAT-up is a suitable screening tool to use in populations of
community-dwelling older people.
In all cohorts, FRAT-up risk score was predictive for future falls.
Without considering the results obtained when ﬁtting and testing a
model on the same population (also known as internal validation56),
we note that for any given test cohort, the FRAT-up discriminative
ability was comparable to or even greater than the other cohort-
speciﬁc risk models. Furthermore, ELSA was the test cohort on
which the models attained the highest and ActiFE the one with the
lowest AUCs, respectively.
Besides differences among the studies in terms of risk factor
prevalence rates and ORs, the I2 statistics indicated substantial het-
erogeneity among the 4 included studies. It is not possible to un-
equivocally determine to which degree this heterogeneity is
attributable to true population dissimilarities (eg, differences in the
distribution of the SPPB score) or to differences in the study protocols
and data collection procedures (eg, methods of recording fall occur-
rences). This limitation is partly due to the lack of consistent dataacross the studies (eg, SPPB is not available in TILDA), and to the small
number of datasets included (ie, 4), therefore, not allowing to conduct
a meta-regression, which might have shed further light on potential
reasons. Nevertheless, ﬁrst a high heterogeneity in terms of risk fac-
tors ORs was already found in the meta-analysis on which FRAT-up
was built.24 Second, some variables and the resulting heterogeneity
might be the result of a sometimes imperfect harmonization process.
For example, estimating exposure to the risk factor “pain” requires
having a consistent and speciﬁc deﬁnition of it. However, in the actual
implementation of the harmonization process, we had to deal with
questionnaires being different across the 4 datasets in terms of fre-
quency (eg, assessment of frequent or occasional pain), reference time
period (eg, 12 months or 2 years before the assessment), or differences
in location (eg, pain in any body location or in speciﬁc areas). There-
fore, some limitations are intrinsic in the 4 different datasets; others
might have been mitigated by an expert consensus process.
Other considerations to explain heterogeneity in results regard the
outcome target variable (ie, occurrence of at least 1 fall in the
12 months after the assessment). First, from theoretical analyses, we
expect that longer follow-ups lead to higher AUCs.57 This may explain
why, excluding results from internal validation, AUC is consistently
higher on ELSA and TILDA, where participants report about falls
experienced during a time period of 2 years, which is twice longer
than in ActiFE and InCHIANTI. Second, the differences in the ap-
proaches used to assess fall incidence could have played a role. In
particular, use of prospective falls calendars (as employed in ActiFE) is
expected to be more precise,30 whereas retrospective questionnaire
assessment (as used in ELSA, InCHIANTI, and TILDA) might register
only more severe fall events, that are supposedly more easily pre-
dictable from information about exposure to standard risk factors.
Finally, the differences in fall incidence among the study populations
provide another potential explanation for the different behavior of
FRAT-up in calibration. In particular, FRAT-up was developed
assuming an average 1-year prevalence of 31% for at least 1 fall.22 This
value is similar to the prevalence of 35% found in ActiFE, where FRAT-
up is substantially calibrated, whereas is much higher than the
prevalence of at least 1 fall of 23% and 21% found in ELSA and
P. Palumbo et al. / JAMDA 17 (2016) 1106e11131112InCHIANTI, respectively, where FRAT-up overestimates the risk. Dis-
crepancies of fall incidence ﬁgures among populations is indeed a
debated issue in the literature.58,59
Externally validating a prediction model means to evaluate the
performance of the model on data that were not used for its devel-
opment. It is of fundamental utility as it allows evaluating the
generalizability of the model outside the derivation cohort. In addi-
tion, it allows estimating its predictive ability excluding some sources
of bias that may intervene in other types of validation procedures.60,61
External validation is rarely performed, partly because it is
time-consuming and costly. Also, in the domain of falls, only few
prediction models for community-dwelling older adults have been
externally validated, and they have shown modest predictive accu-
racy.6,16 By performing a harmonization process, that is connatural
with the FRAT-up 2-block architecture, we have been able to apply and
evaluate this tool on 4 datasets relative to 4 cohort studies of European
older people. The issues discussed above related to the harmonization
process can be thought as the price to pay for avoiding a long and
expensive data collection campaign. However, if FRAT-up is conceived
to be applied on multiple data sources after the construction of spe-
ciﬁc harmonization blocks, our approach to validate it reﬂects its
intended way of using it.Conclusions
Despite extensive research, falls are still difﬁcult to predict because
of the multiplicity of risk factors involved. Applying FRAT-up on
different cohorts where risk factors were assessed according to
different procedures and policies resulted in a risk score that was
signiﬁcantly predictive for falls, although with very heterogeneous
discrimination ability. Overall, FRAT-up seems more suitable to be
transferred across different cohorts than data-driven fall-risk models
stemming from individual cohorts, thereby being a valid option to use
on populations of community-dwelling older people if no speciﬁcally
validated, population-speciﬁc fall risk tools already exist for the
respective population. Nevertheless, further studies should be per-
formed to better understand the reasons for the observed heteroge-
neity and to reﬁne a tool that performs homogeneously with higher
accuracy measures across different populations.Acknowledgments
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